<+Scientific code of ethics>

Our commitment

Trust is the foundation of everything presented at the Artificial Intelligence in Medicine Global Forum 2027 (“AIMed Global Forum 2027”). Work shared here can shape how AI reaches patients, so we hold every contribution to high standards of honesty, transparency and rigour. This Code sets out what we expect from authors and presenters, and how we respond when those standards are not met. It reflects the principles of the Committee on Publication Ethics (COPE, publicationethics.org).

What we expect from authors

Everyone who submits or presents work at AIMed Global Forum 2027 is expected to:

• present their own original work, and give clear credit to the ideas, text, figures and data of others;
• report methods and results honestly, without inventing, altering or selectively hiding data;
• submit work that is not published elsewhere or under review for another venue at the same time;
• list as authors only those who genuinely contributed, and resolve authorship among themselves before submitting;
• obtain any ethical approvals and consents their research requires, and declare relevant conflicts of interest;
• take part in review and revision in good faith, without attempting to influence or manipulate the process.

What we treat as misconduct

Breaches of the above — including plagiarism, data fabrication or falsification, undisclosed duplicate submission, disputed or gift authorship, missing ethical approvals, and interference with peer review — are treated as scientific misconduct. This applies to all abstracts, posters and presentations submitted to or shown at AIMed Global Forum 2027.

How concerns are handled

Anyone — an organizer, reviewer, author or attendee — may raise a concern. Please send it, with any supporting evidence and your contact details, to registration@piebm.org. Reports are handled confidentially.

A concern is first reviewed by the AIMed organizers to judge how serious and well-founded it is; minor matters, such as an accidental missing citation, may be settled at this stage. Anything more serious is referred to the AIMed Scientific / Programme Committee, which reviews the evidence, may ask those involved for further information, and decides on a fair response. The Committee works confidentially and aims to reach a decision without undue delay.

Possible outcomes

Where misconduct is confirmed, and depending on how serious it is, PIEBM may:

• ask the authors to correct the record;
• withdraw or reject the submission;
• bar the authors from submitting to future AIMed events for a set period;
• limit their involvement in AIMed activities such as reviewing or presenting;
• in in serious or repeated cases, and after the matter has been investigated, inform the authors’ institution or employer.